Computer-assisted Prediction of Plausible Metabolites of Xenobiotic Compounds
Author | : Glenn Isamu Ouchi |
Publisher | : |
Total Pages | : 296 |
Release | : 1978 |
Genre | : Biochemistry |
ISBN | : |
Download Computer Assisted Prediction Of Plausible Metabolites Of Xenobiotic Compounds full books in PDF, epub, and Kindle. Read online free Computer Assisted Prediction Of Plausible Metabolites Of Xenobiotic Compounds ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : Glenn Isamu Ouchi |
Publisher | : |
Total Pages | : 296 |
Release | : 1978 |
Genre | : Biochemistry |
ISBN | : |
Author | : Mukund S. Chorghade |
Publisher | : John Wiley & Sons |
Total Pages | : 478 |
Release | : 2006-07-18 |
Genre | : Science |
ISBN | : 047178009X |
From first principles to real-world applications -- here is the first comprehensive guide to drug discovery and development Modern drug discovery and development require the collaborative efforts of specialists in a broadarray of scientific, technical, and business disciplines--from biochemistry to molecular biology, organic chemistry to medicinal chemistry, pharmacology to marketing. Yet surprisingly, until now, there were no authoritative references offering a complete, fully integrated picture of the process. The only comprehensive guide of its kind, this groundbreaking two-volume resource provides an overview of the entire sequence of operations involved in drug discovery and development--from initial conceptualization to commercialization to clinicians and medical practitioners. Volume 1: Drug Discovery describes all the steps in the discovery process, including conceptualizing a drug, creating a library of candidates for testing, screening candidates for in vitro and in vivo activity, conducting and analyzing the results of clinical trials, and modifying a drug as necessary. Volume 2: Drug Development delves into the nitty-gritty details of optimizing the synthetic route, drug manufacturing, outsourcing, and marketing--including drug coloring and delivery methods. Featuring contributions from a world-class team of experts, Drug Discovery and Development: * Features fascinating case studies, including the discovery and development of erythromycin analogs, Tagamet, and Ultiva (remifentanil) * Discusses the discovery of medications for bacterial infections, Parkinson's disease, psoriasis, peptic ulcers, atopic dermatitis, asthma, and cancer * Includes chapters on combinatorial chemistry, molecular biology-based drug discovery, genomics, and chemogenomics Drug Discovery and Development is an indispensable working resource for industrialchemists, biologists, biochemists, and executives who work in the pharmaceutical industry.
Author | : Jitendra Saxena |
Publisher | : Elsevier |
Total Pages | : 481 |
Release | : 2013-10-22 |
Genre | : Business & Economics |
ISBN | : 1483261859 |
Hazard Assessment of Chemicals: Current Developments, Volume 3 is a collection of expertly written articles that provide relevant and important information on the environmental and health hazard assessment of chemicals. The volume presents studies and expositions on such topics as hazard priority ranking system (or scoring system), a method to rank chemicals on the severity of their ill effects on the environment and human health. The book also tackles the effect of particulates on the toxic manifestations of chemicals; application of aquatic organisms as indicator systems for early detection of waterborne human carcinogens; techniques for metal speciation; and impact of fluorocarbons and other contaminants on stratospheric ozone. Environmentalists, ecologists, toxicologists, public safety officers and workers, and those concerned with the health effects of chemical agents in the environment will find this book very informative.
Author | : Manfred Schwab |
Publisher | : Springer Science & Business Media |
Total Pages | : 3307 |
Release | : 2008-09-23 |
Genre | : Medical |
ISBN | : 3540368477 |
This comprehensive encyclopedic reference provides rapid access to focused information on topics of cancer research for clinicians, research scientists and advanced students. Given the overwhelming success of the first edition, which appeared in 2001, and fast development in the different fields of cancer research, it has been decided to publish a second fully revised and expanded edition. With an A-Z format of over 7,000 entries, more than 1,000 contributing authors provide a complete reference to cancer. The merging of different basic and clinical scientific disciplines towards the common goal of fighting cancer makes such a comprehensive reference source all the more timely.
Author | : Pavel Anzenbacher |
Publisher | : John Wiley & Sons |
Total Pages | : 755 |
Release | : 2012-05-29 |
Genre | : Medical |
ISBN | : 352732903X |
A practice-oriented desktop reference for medical professionals, toxicologists and pharmaceutical researchers, this handbook provides systematic coverage of the metabolic pathways of all major classes of xenobiotics in the human body. The first part comprehensively reviews the main enzyme systems involved in biotransformation and how they are orchestrated in the body, while parts two to four cover the three main classes of xenobiotics: drugs, natural products, environmental pollutants. The part on drugs includes more than 300 substances from five major therapeutic groups (central nervous system, cardiovascular system, cancer, infection, and pain) as well as most drugs of abuse including nicotine, alcohol and "designer" drugs. Selected, well-documented case studies from the most important xenobiotics classes illustrate general principles of metabolism, making this equally useful for teaching courses on pharmacology, drug metabolism or molecular toxicology. Of particular interest, and unique to this volume is the inclusion of a wide range of additional xenobiotic compounds, including food supplements, herbal preparations, and agrochemicals.
Author | : Amit S. Kalgutkar |
Publisher | : John Wiley & Sons |
Total Pages | : 445 |
Release | : 2012-09-06 |
Genre | : Medical |
ISBN | : 352765576X |
Closing a gap in the scientifi c literature, this first comprehensive introduction to the topic is based on current best practice in one of the largest pharmaceutical companies worldwide. The first chapters trace the development of our understanding of drug metabolite toxicity, covering basic concepts and techniques in the process, while the second part details chemical toxicophores that are prone to reactive metabolite formation. This section also reviews the various drug-metabolizing enzymes that can participate in catalyzing reactive metabolite formation, including a discussion of the structure-toxicity relationships for drugs. Two chapters are dedicated to the currently hot topics of herbal constituents and IADRs. The next part covers current strategies and approaches to evaluate the reactive metabolite potential of new drug candidates, both by predictive and by bioanalytical methods. There then follows an in-depth analysis of the toxicological potential of the top 200 prescription drugs, illustrating the power and the limits of the toxicophore concept, backed by numerous case studies. Finally, a risk-benefi t approach to managing the toxicity risk of reactive metabolite-prone drugs is presented. Since the authors carefully develop the knowledge needed, from fundamental considerations to current industry standards, no degree in pharmacology is required to read this book, making it perfect for medicinal chemists without in-depth pharmacology training.
Author | : Johannes Kirchmair |
Publisher | : John Wiley & Sons |
Total Pages | : 538 |
Release | : 2014-08-25 |
Genre | : Medical |
ISBN | : 3527335668 |
The first professional reference on this highly relevant topic, for drug developers, pharmacologists and toxicologists. The authors provide more than a systematic overview of computational tools and knowledge bases for drug metabolism research and their underlying principles. They aim to convey their expert knowledge distilled from many years of experience in the field. In addition to the fundamentals, computational approaches and their applications, this volume provides expert accounts of the latest experimental methods for investigating drug metabolism in four dedicated chapters. The authors discuss the most important caveats and common errors to consider when working with experimental data. Collating the knowledge gained over the past decade, this practice-oriented guide presents methods not only used in drug development, but also in the development and toxicological assessment of cosmetics, functional foods, agrochemicals, and additives for consumer goods, making it an invaluable reference in a variety of disciplines.